Erhart, C.-C., Cefalì M., Mangan , D., Kasenda , B., & Wannesson, L. (2024). Prognostic value of KRAS G12C in advanced non-small cell lung cancer with high PD-L1 expression treated with upfront immunotherapy: a systematic review and meta-analysis. Swiss Medical Weekly, 154(7), 3695. https://doi.org/10.57187/s.3695